Intermap's Q1 2026 revenue printed down 67% year over year. Management reaffirmed full-year guidance anyway. The market took the print at face value: ITMSF (≈$100M market cap, OTC, single analyst) sits near a 52-week low, roughly the price five insiders paid 38 days ago. The Indonesian government's BIG procurement portal explains the apparent contradiction. The catalyst is dated, the bidding is in progress, and the listed competitors aren't on the bid sheet.

What the filing says

• Q1 2026 revenue $1.4M vs $4.3M prior year. FY2026 guidance $30-35M reaffirmed at 28% EBITDA margin. Implied Q2-Q4 ramp of $28-34M from a $1.4M Q1 base depends on government program awards landing in H2.
• Cash $18.8M vs $22.5M at year-end 2025. CFO attributed the $3.7M Q1 burn to NASDAQ uplist preparation and Indonesia mobilization, not operating loss; commercial business is near operating breakeven.
• Commercial recurring ARR through $7M, approaching $8M, guided to $10M. Recurring is >80% of total revenue. Eight leading Czech insurers — described as the majority of the residential property market — are on the platform; Generali is expanding from the Czech base into broader Europe.
• CEO named all six US Combatant Commands as "active right now" needing GEOINT; NOAA IDIQs cited at ≈$500M combined ceiling.
• NASDAQ uplisting: legal, PCAOB audit, and FPI filings complete; gating on dealer / market maker support. CEO described status as "getting very close."
• On Indonesia ILASPP Phase 2 ($200M+ potential, $40-50M upfront on signing), CEO declined to elaborate: "I'm not going to speculate on where they sit with it right now specifically. It is fluid." On World Bank financing timing: "I don't want to comment further on it at this time." When pressed on revenue trajectory, CEO directed analysts to "look at things like the balance sheet and contract liability" — implying deferred revenue is building ahead of recognition.
• Sulawesi 2024: ITMSF holds the prior $20M One Map Program award covering ≈10% of country area, executed in partnership with PT Pratama Persada Airborne (PPA), a state-owned subsidiary.

What the market thinks

Three-month average daily volume ≈0.4M shares. Sole sell-side coverage carries a $3.94 price target.

A sum-of-parts floor — cash ($0.27/share) plus commercial SaaS at 8x ARR ($0.79-$0.90/share) — runs $1.13-$1.31/share. Current price implies the catalyst pipeline is worth roughly $0.10-$0.30/share, or about 5-15% of the disclosed Indonesia opportunity if it lands. Back-solving the price against the factor scenario (bull around +120%, bear around -54%, neutral near current) implies the market is pricing the bear state at roughly 2x the probability of the bull state. Our read of the procurement timeline reverses that ratio.

Why the gap exists

This is a public-information mispricing. Three pieces of synthesis aren't being done.

The BIG procurement portal publishes a live, dated timeline. ilaspp-proc.big.go.id shows financial bid openings on May 13, 2026 (Urban Areas, already passed) and May 20, 2026 (Non-Urban Areas, five days from now), with the parallel QC/QA consultancy track scheduling Notification of Award for approximately July 23, 2026. The World Bank approved the $653M ILASP financing facility on September 30, 2024. The portal is in Indonesian and is not surfaced by English-language financial media.

The April 7 insider cluster sits exactly 36 days before the financial bid opening window. Five insiders — CFO, two senior officers, two directors — bought a combined ≈$702K at ≈$1.41 on the same day, five weeks before a Q1 print they had visibility into. Pattern matches our cyclical-trough-coordinated-insider-buying framework on every dimension (count ≥3, coordinated, at trough, analyst coverage ≤3), with same-day rather than same-week coordination. No published research has connected the insider timing to the procurement calendar.

Listed GEOINT competitors aren't on the bid sheet. BlackSky, Planet, Satellogic, and MDA Space all sell satellite imagery products. The BIG technical specification — 1:5,000 topographic basemap with cloud and foliage penetration over rainforest — was selected through a multi-year SAR community evaluation that identified airborne IFSAR as the qualifying technology. Spaceborne SAR is excluded by spec. ITMSF + PPA holds the technical fit, the local-content position, and Sulawesi-stage incumbency. The competitive overhang investors might worry about doesn't exist on the listed side.

The CEO's hedged language reads as procedural sealed-bid compliance once mapped against the portal — not competitive deterioration.

Risks (ranked)

1. Private competitors we cannot observe. Iceye has airborne capability and has won national mapping programs globally. Other airborne IFSAR consortia exist privately. Their bids are not visible to public-source research. The single largest source of bear-case probability sits in this blind spot.
2. Third procurement extension. The World Bank has extended this timeline twice. A third extension defers resolution into Q4 2026 and tightens cash runway against catalyst recognition.
3. Q2 2026 earnings (~August 13). Revenue almost certain to print weak (catalyst doesn't sign before earliest July 31). The print itself doesn't kill the thesis but pressures the stock pre-catalyst.
4. Capital raise risk. $18.8M cash supports roughly five quarters at current burn. Slippage past Q1 2027 introduces equity raise risk at depressed prices.
5. OTC liquidity asymmetry. A win produces a limit-up gap difficult to fill at scale; a loss sees bids disappear.

Catalysts

• May 20, 2026 — BIG public opening of financial bids (Non-Urban Areas)
• ~June 22, 2026 — Combined technical/financial evaluation
• ~July 23, 2026 — Notification of Award
• ~July 31, 2026 — Contract signing (if won); $40-50M upfront recognition
• ~August 13, 2026 — Q2 2026 earnings (likely below $5M revenue)
• By September 30, 2026 — NASDAQ uplisting deadline (decoupled second leg)

What would change our mind

• BIG portal posts a third extension to financial bid opening — procurement integrity weakens
• Iceye announces Indonesian engagement — competitive disambiguation invalidated
• Notification of Award names a different prime contractor exclusively — bull case falsified
• ITMSF announces a capital raise before July 31 — implies management hedging the catalyst; retroactively weakens the April 7 insider signal
• Insider selling between now and Notification of Award — Form 4 signal inversion
• Q1 2026 6-K shows contract liabilities flat or declining sequentially — invalidates the CEO's own tell ("look at the balance sheet"); weakens the deferred-revenue cushion under the bear states

Evidence